AnPac Bio Reports Nine Months Ended September 30, 2021,

PHILADELPHIA, Nov. 26, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology...

Related Keywords

China ,Taiwan ,United States ,Philadelphia ,Pennsylvania ,Chris Chang Yu ,Anpac Bio ,Chris Yu ,Tina Xiao ,Science Co Ltd ,Nasdaq ,Development Expenses ,Exchange Commission ,Laboratory Developed Test ,Securities Exchange ,Ascent Investor Relations ,Pac Bio ,Nine Months Ended September ,Anpai Shanghai ,Financial Results ,Cancer Differentiation Analysis ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Annual Report ,Nasdaq Anpc ,Sa ,